DataMeds AI, Inc. Increase (Decrease) in Accounts Receivable
DataMeds AI, Inc. (MEDS) reported Increase (Decrease) in Accounts Receivable of $250.90 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-17
- DataMeds AI, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $302.28K.
- DataMeds AI, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$51.38K, a 128.53% decline year-over-year.
- DataMeds AI, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $560.06K, a 18681.46% increase year-over-year.
- DataMeds AI, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$996.92K, a 2791.84% decline year-over-year.
- DataMeds AI, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$799.77K, a 2095.39% decline from fiscal 2024.
- DataMeds AI, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $40.08K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $302.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $250.90K 10-Q · filed 2026-08-17 | $810.97K derived: sum of 3 quarters · filed 2026-08-17 | -$185.96K derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | -$51.38K 10-Q · filed 2026-05-19 | $508.69K derived: sum of 2 quarters · filed 2026-05-19 | -$488.24K derived: sum of 3 quarters · filed 2026-05-19 | -$1.03M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $560.06K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | -$436.86K derived: sum of 2 quarters · filed 2026-03-20 | -$979.87K derived: sum of 3 quarters · filed 2026-08-17 | -$799.77K 10-K · filed 2026-03-20 |
| 2025-09-30 | -$996.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$1.54M derived: sum of 2 quarters · filed 2026-08-17 | -$1.36M 10-Q · filed 2025-11-19 | -$1.36M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | -$543.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$362.91K 10-Q · filed 2026-08-17 | -$359.93K derived: sum of 3 quarters · filed 2026-08-17 | -$322.89K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $180.10K 10-Q · filed 2026-05-19 | $183.08K derived: sum of 2 quarters · filed 2026-05-19 | $220.12K derived: sum of 3 quarters · filed 2026-05-19 | |
| 2024-12-31 | $2.98K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $40.02K derived: sum of 2 quarters · filed 2026-03-20 | $40.08K 10-K · filed 2026-03-20 | |
| 2024-09-30 | $37.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $37.10K 10-Q · filed 2025-11-19 | ||
| 2024-06-30 | $64.00 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |